Sugammadex clinical trials
Also written Bridion, Org 25969 and MK-8616.
How each study uses Sugammadex is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Sugammadex studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 15 Dec 2015 · BRIDION · NDA 022225 (FDA, Drugs@FDA)
- European Union
- 25 Jul 2008 · Bridion · EMEA/H/C/000885 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
201 studies that test it; most in 2017 (21)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 12 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 6 |
| 2009 | 2 |
| 2010 | 6 |
| 2011 | 9 |
| 2012 | 9 |
| 2013 | 8 |
| 2014 | 12 |
| 2015 | 13 |
| 2016 | 8 |
| 2017 | 21 |
| 2018 | 15 |
| 2019 | 14 |
| 2020 | 8 |
| 2021 | 10 |
| 2022 | 7 |
| 2023 | 13 |
| 2024 | 13 |
| 2025 | 4 |
| 2026 | 4 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 41 · Other 160
Merck Sharp & Dohme LLC (39) · Seoul National University Hospital (6) · Seoul National University Bundang Hospital (5) · Guangzhou General Hospital of Guangzhou Military Command (4) · University of Texas Southwestern Medical Center (4) · Ajou University School of Medicine (4) · West Virginia University (3) · Mansoura University (3)
Often tested with
Tested in the same studies.
Neostigmine (37) · Rocuronium (23) · Glycopyrrolate (10) · Atropine (4) · Vecuronium (3) · Succinylcholine (3) · Cisatracurium (2) · Pyridostigmine (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 5, 1 in phase 3
Studies that test Sugammadex, phase 3 first.
- Nov 2027Neuromuscular Blocking Agents on Gastrointestinal Function Following Colorectal SurgeryPhase 3 · Xijing Hospital
- Nov 2026Venous Tourniquet vs. Arterial Tourniquet for Seizure Monitoring in ECTNot applicable · Medipol University
- Dec 2026Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney DiseasePhase 4 · The University of Texas Medical Branch, Galveston
- Aug 2027A Dose-response Study to Determine the Right Dosage of Sugammadex as a Reversal Agent of Rocuronium in Infants Between 1 and 24 Months OldPhase 4 · University Hospital, Caen
- Aug 2027Pharmacological Reversal of Neuromuscular Blockade in Critically Ill PatientsNot applicable · Seoul National University Hospital
Studies
Open first, then newest update. How each study uses Sugammadex is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 201
- Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney DiseaseRecruitingPhase 4The University of Texas Medical Branch, GalvestonNCT07203287Written as SugammadexHow we know
- Venous Tourniquet vs. Arterial Tourniquet for Seizure Monitoring in ECTRecruitingNot applicableMedipol UniversityNCT07534475Written as SugammadexHow we know
- Sugammadex-Induced Clenching During Neuromuscular Blockade ReversalRecruitingNot applicableWonkwang University HospitalNCT06962007Written as Sugammadex 1 mg/kg GroupHow we know
- Impact of Sugammadex Versus Neostigmine on Early Postoperative Pulmonary FunctionRecruitingNot applicableShanghai Pulmonary Hospital, Shanghai, ChinaNCT07309393Written as SugammadexHow we know
- Pharmacological Reversal of Neuromuscular Blockade in Critically Ill PatientsRecruitingNot applicableSeoul National University HospitalNCT05993390Written as SugammadexHow we know
- A Dose-response Study to Determine the Right Dosage of Sugammadex as a Reversal Agent of Rocuronium in Infants Between 1 and 24 Months OldNot yet recruitingPhase 4University Hospital, CaenNCT07477132Written as SugammadexHow we know
- Placental Transfer of Sugammadex in the Human Placental Perfusion ModelEnrolling by invitationNot applicableUniversitaire Ziekenhuizen KU LeuvenNCT06634355Written as SugammadexHow we know
- Neuromuscular Blocking Agents on Gastrointestinal Function Following Colorectal SurgeryNot yet recruitingPhase 3Xijing HospitalNCT07271875Written as SugammadexHow we know
- The Clinical Effect of Sugammadex Sodium (Domestic) for Antagonizing Neuromuscular Blockade After Thoracic SurgeryRecruitingNot applicableThe Fourth Affiliated Hospital of Zhejiang University School of MedicineNCT06334562Written as SUGAMMADEX SODIUM 100 Mg in 1 mLHow we know
- Recovery Times of Half Dose Sugammadex and Neostigmine for Rocuronium-induced Neuromuscular BlockadeRecruitingPhase 1/2Universitas PadjadjaranNCT06794450Written as Sugammadex 1 mg/kgHow we know
- Sugammadex on Laparoscopic Bariatric SurgeryNot yet recruitingNot applicableShanxi Bethune HospitalNCT06678451Written as SugammadexHow we know
- Sugammadex Dose Finding Under Two Years OldNot yet recruitingPhase 2Sang-Hwan JiNCT06575036Written as SugammadexHow we know
- Deep Versus Moderate Neuromuscular Blockade in Bariatric SurgeryNot yet recruitingNot applicableUniversity Hospital of PatrasNCT06553066Written as Deep neuromascular blockageHow we know
- Effectiveness on Smooth Extubation According to the Administration Time of SugammadexNot yet recruitingNot applicableAjou University School of MedicineNCT05751603Written as sugammadexHow we know
- Effects of Sugammadex and Conventional Reversal on Lung Function in Laparoscopic Abdominal SurgeryRecruitingNot applicableRhendra Hardy Mohamad ZainiNCT06210165Written as SugammadexHow we know
- The Effect of Neostigmine and Sugammadex on the Optic Nerve Sheath DiameterCompletedPhase 4Cukurova UniversityNCT07666984Written as Sugammadex 2 mg/kgHow we know
- Sugammadex vs Neostigmine/Glycopyrrolate on Urinary Retention After Spine SurgeryCompletedPhase 4University of Missouri-ColumbiaNCT05887375Written as SugammadexHow we know
- Pharmacokinetics and Pharmacodynamics of Sugammadex Dosed by Corrected Body Weight for Reversal of Vecuronium in Obese PatientsCompletedPhase 4Guangzhou General Hospital of Guangzhou Military CommandNCT05328778Written as SugammadexHow we know
- Neuromuscular Blockade Comparison for GI-2 Recovery After Bowel ResectionCompletedPhase 4University of California, IrvineNCT06112353Written as Sugammadex injectionHow we know
- The Occurrence of Emergence Agitation in Pediatric Strabismus SurgeryCompletedPhase 4Konkuk University Medical CenterNCT06035757Written as Bridion 200 MG in 2 ML InjectionHow we know
See all 201 studies that test Sugammadex →
Given beside what is tested · 8 — Sugammadex is usual care or a partner of the new treatment
- Minimal Flow Anesthesia and Infection RiskCompletedNot applicableAnkara City Hospital BilkentNCT07092046Written as Sugammadex 200 MG in 2 ML InjectionHow we know
- Designing Optimal Prevention and Management of Postoperative Nausea and Emesis for Patients Undergoing Laparoscopic Sleeve GastrectomyCompletedPhase 4Stony Brook UniversityNCT03435003Written as SugammadexHow we know
- Deep vs Moderate Neuromuscular Blockade With Rocuronium in Patients Undergoing Endolaryngeal ProceduresCompletedPhase 4Chulalongkorn UniversityNCT02451202Written as SugammadexHow we know
- Sugammadex After Continuous Infusion of Rocuronium During Sevoflurane and Propofol Anesthesia (P05949; MK-8616-028)CompletedPhase 3Merck Sharp & Dohme LLCNCT00559468Written as SugammadexHow we know
- "Low Dose Sugammadex Combined With Neostigmine and Glycopyrrolate Versus Full Dose Sugammadex for Reversal of Rocuronium-induced Neuromuscular Blockade: a Cost Saving Strategy"CompletedPhase 4American University of Beirut Medical CenterNCT02375217Written as SugammadexHow we know
- Effect of Dexamethasone on the Action of SugammadexCompletedNot applicableAttikon HospitalNCT02510157Written as sugammadexHow we know
- Atropine in Laparoscopic Gynaecological SurgeryStatus unknownPhase 4Clinica Santa MariaNCT02769325Written as sugammadexHow we know
- Effects of Magnesium Sulphate on Sugammadex Reversal of Rocuronium Induced Blockade in Gynaecology PatientsCompletedPhase 4Kocaeli UniversityNCT01972659Written as sugammadexHow we know
As the comparator · 4 — what is tested is compared with Sugammadex
- REMIfentanil (2 vs. 4 mcg/kg) Facilitated Intubation Without Neuromuscular Blockade Versus Succinylcholine and Rocuronium With Sugammadex for Endotracheal Intubation in Spine Surgery Requiring Motor Evoked Potential MonitoringNot yet recruitingPhase 4Mayo ClinicNCT07835295Written as SugammadexHow we know
- Study of Recovery of Strength After Surgery Comparing Two Different Medications for Reversal of Muscle RelaxantCompletedPhase 3Memorial Sloan Kettering Cancer CenterNCT03116997Written as SugammadexHow we know
- Electromyographic Activity of the Respiratory Muscles During Neostigmine or Sugammadex Enhanced Recovery After Neuromuscular BlockadeCompletedPhase 4Onze Lieve Vrouw HospitalNCT02403063Written as SugammadexHow we know
- A Double-blind, Randomized, Parallel Design Study to Compare the Effectiveness of Sugammadex Versus Neostigmine in Improving Surgical Condition in Subjects Undergoing Laryngeal MicrosurgeryCompletedNot applicableYonsei UniversityNCT01980069Written as SugammadexHow we know
Codes
What other systems call Sugammadex · ClinicalTrials.gg INT006645
- MeSH (NLM) D000077122SugammadexConfirmed NLM, Wikidata
- UNII (FDA) 361LPM2T56SUGAMMADEXConfirmed FDA, NLM, Wikidata
- RxNorm 1726988Confirmed FDA, Wikidata
- Wikidata Q81987842sugammadexConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C80629SugammadexOne source FDA
- DrugBank DB06206One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077122 | Sugammadex | Confirmed NLM, Wikidata |
| UNII (FDA) | 361LPM2T56 | SUGAMMADEX | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1726988 | — | Confirmed FDA, Wikidata |
| Wikidata | Q81987842 | sugammadex | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C80629 | Sugammadex | One source FDA |
| DrugBank | DB06206 | — | One source Wikidata |
Also registered as sugammadex sodium (UNII ERJ6X2MXV7 · RxNorm 1726987).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.